Gerd Ritter

19.5k citations

182 papers · 14.3k · 2 hit papers · h-index 62

Impact in

Immunology top 0.1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in

Immunology 108
- Immunotherapy and Immune Responses 95
- T-cell and B-cell Immunology 44
- Immune Cell Function and Interaction 33
Molecular Biology 92
- Glycosylation and Glycoproteins Research 39
- vaccines and immunoinformatics approaches 33

Co-authors: Lloyd J. Old (117 shared papers)Sacha Gnjatic (56 shared papers)Achim A. Jungbluth (28 shared papers)Yao‐Tseng Chen (17 shared papers)Elke Jäger (24 shared papers)Alexander Knuth (23 shared papers)Kunle Odunsi (16 shared papers)Hiroyoshi Nishikawa (10 shared papers)
Journals: Proceedings of the National Academy of Sciences (18 papers)International Journal of Cancer (11 papers)The Journal of Immunology (9 papers)Blood (8 papers)Journal of Clinical Oncology (6 papers)
Partner nations: United States Germany Switzerland

In The Last Decade

Gerd Ritter

181 papers receiving 14.1k citations

Gerd Ritter's Hit Papers

align trajectories log scale

Integrated NY-ESO-1 antibody and CD8 ⁺ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab 2011 · 255 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2011 Proceedings of the National Academy of Sciences
2005 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Gerd Ritter

Since Specialization

Citations

This map shows the geographic impact of Gerd Ritter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerd Ritter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerd Ritter more than expected).

Fields of papers citing papers by Gerd Ritter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerd Ritter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerd Ritter. The network helps show where Gerd Ritter may publish in the future.

Co-authors

The 25 scholars most cited alongside Gerd Ritter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerd Ritter Line = papers co-authored together Gerd Ritter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 182 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Intraepithelial CD8 ⁺ tumor-infiltrating lymphocytes and a high CD8 ⁺ /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer Proceedings of the National Academy of Sciences ·Eiichi Sato, Sara H. Olson, Jiyoung Ahn, Brian N. Bundy, Hiroyoshi Nishikawa, Feng Qian, Achim A. Jungbluth, Denise Frosina, Sacha Gnjatic, Christine B. Ambrosone, James L. Kepner, Tosin Odunsi, Gerd Ritter, Shashikant Lele, Yao‐Tseng Chen, Haruo Ohtani, Lloyd J. Old, Kunle Odunsi Hit paper breakdown →	2005	1888
2	Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside. Journal of Clinical Oncology ·Philip O. Livingston, Gabriel Wong, Sucharita Adluri, (unknown), M Padavan, R Parente, Christine Hanlon, M J Calves, Friedhelm Helling, Gerd Ritter	1994	420
3	NKT Cells Enhance CD4+ and CD8+ T Cell Responses to Soluble Antigen In Vivo through Direct Interaction with Dendritic Cells The Journal of Immunology ·Ian F. Hermans, Jonathan D. Silk, Uzi Gileadi, Mariolina Salio, Bini Mathew, Gerd Ritter, Richard R. Schmidt, Adrian L. Harris, Lloyd J. Old, Vincenzo Cerundolo	2003	383
4	Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers Proceedings of the National Academy of Sciences ·Elke Jäger, Sacha Gnjatic, Yasuhiro Nagata, Elisabeth Stockert, Dirk Jäger, Julia Karbach, Antje Neumann, Julia Rieckenberg, Yao‐Tseng Chen, Gerd Ritter, Eric W. Hoffman, Michael Arand, Lloyd J. Old, Alexander Knuth	2000	363
5	Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses Proceedings of the National Academy of Sciences ·Elke Jäger, Yasuhiro Nagata, Sacha Gnjatic, Hisashi Wada, Elisabeth Stockert, Julia Karbach, P. Rod Dunbar, Sang Yull Lee, Achim A. Jungbluth, Dirk Jäger, Michael Arand, Gerd Ritter, Vincenzo Cerundolo, Bo Dupont, Yao‐Tseng Chen, Lloyd J. Old, Alexander Knuth	2000	337
6	The crystal structure of human CD1d with and without α-galactosylceramide Nature Immunology ·Michael Koch, Victoria S. Stronge, Dawn Shepherd, Stephan D. Gadola, Bini Mathew, Gerd Ritter, Alan R. Fersht, Gurdyal S. Besra, Richard R. Schmidt, E. Yvonne Jones, Vincenzo Cerundolo	2005	329
7	Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer Clinical Cancer Research ·Ali O. Güre, Ramon Chua, Barbara Williamson, Mithat Gönen, Cathy A. Ferrera, Sacha Gnjatic, Gerd Ritter, Andrew J.G. Simpson, Yao-T. Chen, Lloyd J. Old, Nasser K. Altorki	2005	293
8	NY‐ESO‐1: Review of an Immunogenic Tumor Antigen Advances in cancer research ·Sacha Gnjatic, Hiroyoshi Nishikawa, Achim A. Jungbluth, Ali O. Güre, Gerd Ritter, Elke Jäger, Alexander Knuth, Yao‐Tseng Chen, Lloyd J. Old	2006	281
9	CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit Proceedings of the National Academy of Sciences ·Jianda Yuan, Sacha Gnjatic, Hao Li, Sarah Powel, Humilidad F. Gallardo, Erika Ritter, Geoffrey Y. Ku, Achim A. Jungbluth, Neil H. Segal, Teresa Rasalan, Gregor Manukian, Yinyan Xu, Ruth-Ann Roman, Stephanie Terzulli, Melanie Heywood, Evelina Pogoriler, Gerd Ritter, Lloyd J. Old, James P. Allison, Jedd D. Wolchok	2008	268
10	Integrated NY-ESO-1 antibody and CD8 ⁺ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab Proceedings of the National Academy of Sciences ·Jianda Yuan, Matthew Adamow, Brian Ginsberg, Teresa Rasalan, Erika Ritter, Humilidad F. Gallardo, Yinyan Xu, Evelina Pogoriler, Stephanie Terzulli, Deborah Kuk, Katherine S. Panageas, Gerd Ritter, Mario Sznol, Ruth Halaban, Achim A. Jungbluth, James P. Allison, Lloyd J. Old, Jedd D. Wolchok, Sacha Gnjatic Hit paper breakdown →	2011	255
11	Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming Proceedings of the National Academy of Sciences ·Danila Valmori, Naira E. Souleimanian, Valeria Tosello, Nina Bhardwaj, Sylvia Adams, David O’Neill, Anna C. Pavlick, Juliet Escalon, Crystal Cruz, Angelica Angiulli, Francesca Angiulli, Gregory Mears, Susan Vogel, Linda Pan, Achim A. Jungbluth, Eric W. Hoffmann, Ralph Venhaus, Gerd Ritter, Lloyd J. Old, Maha Ayyoub	2007	242
12	Colon cancer associated transcript‐1: A novel RNA expressed in malignant and pre‐malignant human tissues International Journal of Cancer ·Aviram Nissan, Alexander Stojadinovic, Stella Mitrani‐Rosenbaum, David Halle, Ronit Grinbaum, Marina Roistacher, Andrea E. Bochem, Barış Emre Dayanç, Gerd Ritter, İsmail Gömceli, Erdal Birol Bostancı, Musa Akoğlu, Yao‐Tseng Chen, Lloyd J. Old, Ali O. Güre	2011	240
13	PEGylated Gold Nanoparticles Conjugated to Monoclonal F19 Antibodies as Targeted Labeling Agents for Human Pancreatic Carcinoma Tissue ACS Nano ·Wolfgang Eck, Gary A. Craig, Aruna Sigdel, Gerd Ritter, Lloyd J. Old, Laura H. Tang, Murray F. Brennan, Peter J. Allen, Michael D. Mason	2008	235
14	Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer Proceedings of the National Academy of Sciences ·Kunle Odunsi, Feng Qian, Junko Matsuzaki, Paulette Mhawech‐Fauceglia, Chris Andrews, Eric W. Hoffman, Linda Pan, Gerd Ritter, Jeannine Villella, Bridget V. Thomas, Kerry J. Rodabaugh, Shashikant Lele, Protul Shrikant, Lloyd J. Old, Sacha Gnjatic	2007	215
15	Structure of human CD1b with bound ligands at 2.3 Å, a maze for alkyl chains Nature Immunology ·Stephan D. Gadola, Nathan R. Zaccai, Karl Harlos, Dawn Shepherd, Julio C. Castro‐Palomino, Gerd Ritter, Richard R. Schmidt, E. Yvonne Jones, Vincenzo Cerundolo	2002	215
16	NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer. PubMed ·Kunle Odunsi, Achim A. Jungbluth, Elisabeth Stockert, Feng Qian, Sacha Gnjatic, Jonathan Tammela, Marilyn Intengan, Amy Beck, Bernadette Keitz, Darren Santiago, Barbara Williamson, Matthew J. Scanlan, Gerd Ritter, Yao‐Tseng Chen, Deborah Driscoll, Ashwani Sood, Shashikant Lele, Lloyd J. Old	2003	209
17	Dramatically Different Phenotypes in Mouse Models of Human Tay-Sachs and Sandhoff Diseases Human Molecular Genetics ·Daniel J. Phaneuf, Nobuaki Wakamatsu, Jingqi Huang, A Borowski, Alan C. Peterson, Sheila R. Fortunato, Gerd Ritter, Suleiman A. Igdoura, Carlos R. Morales, Guylaine Benoit, Beverly R. Akerman, Daniel Leclerc, Nobuo Hanai, Jamey D. Marth, Jacquetta M. Trasler, R A Gravel	1996	206
18	Identification of Ny-Eso-1 Epitopes Presented by Human Histocompatibility Antigen (Hla)-Drb40101–0103 and Recognized by Cd4+T Lymphocytes of Patients with Ny-Eso-1–Expressing Melanoma The Journal of Experimental Medicine* ·Elke Jäger, Dirk Jäger, Julia Karbach, Yao‐Tseng Chen, Gerd Ritter, Yasuhiro Nagata, Sacha Gnjatic, Elisabeth Stockert, Michael Arand, Lloyd J. Old, Alexander Knuth	2000	186
19	Humoral immune responses of cancer patients against “Cancer-Testis” antigen NY-ESO-1: Correlation with clinical events International Journal of Cancer ·Elke Jäger, Elisabeth Stockert, Zacharias Zidianakis, Yao‐Tseng Chen, Julia Karbach, Dirk Jäger, Michael Arand, Gerd Ritter, Lloyd J. Old, Alexander Knuth	1999	182
20	A Significant Number of Human Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes Detected by Tetramer Binding Do Not Produce Gamma Interferon Journal of Virology ·Paul Goepfert, Anju Bansal, Bradley H. Edwards, Gerd Ritter, Ildefonso Téllez, Sylvia A. McPherson, Steffanie Sabbaj, Mark J. Mulligan	2000	175

About Gerd Ritter

Gerd Ritter is a scholar working on Immunology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Oncology and Biotechnology, having authored 182 papers that have together received 14.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (95 papers), Monoclonal and Polyclonal Antibodies Research (47 papers), T-cell and B-cell Immunology (44 papers), Glycosylation and Glycoproteins Research (39 papers), Immune Cell Function and Interaction (33 papers), vaccines and immunoinformatics approaches (33 papers), HIV Research and Treatment (12 papers) and Cancer Immunotherapy and Biomarkers (11 papers). The work is most often cited by research in Immunology (8.5k citations), Oncology (4.7k citations), Virology (635 citations), Radiology, Nuclear Medicine and Imaging (1.6k citations) and Molecular Biology (5.0k citations). Gerd Ritter has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Lloyd J. Old, Sacha Gnjatic, Achim A. Jungbluth, Yao‐Tseng Chen, Elke Jäger, Alexander Knuth, Kunle Odunsi, Hiroyoshi Nishikawa, Shashikant Lele and Elisabeth Stockert. Their work appears in journals such as Proceedings of the National Academy of Sciences, International Journal of Cancer, The Journal of Immunology, Blood and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Gerd Ritter

Impact in

Papers in i

In The Last Decade

Gerd Ritter

Gerd Ritter's Hit Papers

Peers

Countries citing papers authored by Gerd Ritter

Fields of papers citing papers by Gerd Ritter

All Works

About Gerd Ritter

Explore authors with similar magnitude of impact

Papers in